Azopharma Product Development Group has entered the microdosing market and will provide services to synthesize material open to microdose studies as well as formulate and administer microdoses in a clinical setting, and analyze samples.     Microdosing involves the use of radiolabeled materials at very low levels where patients are dosed at 1/100 of the anticipated therapeutic dose. Samples are then analyzed with an Accelerate Mass Spectrometer (AMS), which is capable of detecting the labele...